IPOs and Secondaries
IPOs and Secondaries Articles
Audentes Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Bavarian Nordic has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Collegium Pharmaceutical has filed with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering valued at $86.25 million.
Published:
Last Updated:
Shimmick Construction expects to price more than 6 million shares in the range of $11 to $13, valuing its IPO at up to more than $93 million.
Published:
Last Updated:
Elevate Credit has amended its filing with the U.S. Securities and Exchange Commission for its initial public offering (IPO).
Published:
Last Updated:
Sancilio Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Unicorns are private companies that have raised venture capital with valuations in excess of $1 billion dollars. Here are 11 unicorns that might see IPOs start coming to light in 2016.
Published:
Last Updated:
Laureate Education has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
Univision Holdings has amended its filing with U.S. the Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Proteostasis Therapeutics has registered an S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
AnaptysBio has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
The 2015 initial public offering (IPO) season ended with China’s online lending marketplace Yirendai Ltd. (NYSE: YRD) came public on December 18th with a whimper, not a bang. The last IPO of the...
Published:
Last Updated:
Acacia Communications has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Collegium Pharmaceutical has filed with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering.
Published:
Last Updated:
KemPharm expects to price its 3 million shares around last Thursday's closing price of $18.88, which would value the entire secondary offering at up to more than $65 million.
Published:
Last Updated: